BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21439516)

  • 41. Are penicillins still relevant for empirical treatment in contemporary pediatric therapeutics?
    Onalo R; Adeleke IS; Onalo V
    Ann Afr Med; 2013; 12(1):59-60. PubMed ID: 23481000
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time trends in the epidemiology of microbial infections at a tertiary care center in west India over last 5 years.
    Patel AK; Patel KK; Patel KR; Shah S; Dileep P
    J Assoc Physicians India; 2010 Dec; 58 Suppl():37-40. PubMed ID: 21563612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in antimicrobial resistance among today's bacterial pathogens.
    Thornsberry C
    Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview perspective of bacterial resistance.
    Furtado GH; Nicolau DP
    Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI)].
    Dorobăţ OM; Moisoiu A; Tălăpan D
    Pneumologia; 2007; 56(1):7-15. PubMed ID: 17491203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of isolation and antimicrobial susceptibility pattern of bacterial isolates from blood culture, Gondar University teaching hospital, Northwest Ethiopia.
    Ali J; Kebede Y
    Ethiop Med J; 2008 Apr; 46(2):155-61. PubMed ID: 21309205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002).
    Turner PJ
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):281-9. PubMed ID: 15808320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

  • 51. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India.
    Wattal C; Goel N; Oberoi JK; Raveendran R; Datta S; Prasad KJ
    J Assoc Physicians India; 2010 Dec; 58 Suppl():32-6. PubMed ID: 21563611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteriological investigation of infected pressure ulcers in spinal cord-injured patients and impact on antibiotic therapy.
    Heym B; Rimareix F; Lortat-Jacob A; Nicolas-Chanoine MH
    Spinal Cord; 2004 Apr; 42(4):230-4. PubMed ID: 15060520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro evaluation of activity of tigecycline against susceptible and multidrug resistant organisms.
    Gupta V; Bansal N; Chander J
    Indian J Med Microbiol; 2012; 30(4):483-5. PubMed ID: 23183481
    [No Abstract]   [Full Text] [Related]  

  • 55. Current status of antimicrobial resistance in Taiwan.
    Hsueh PR; Liu CY; Luh KT
    Emerg Infect Dis; 2002 Feb; 8(2):132-7. PubMed ID: 11897063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates.
    Jumaa PA; Neringer R
    J Chemother; 2005 Aug; 17(4):376-9. PubMed ID: 16167515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of ceftobiprole against Gram-positive and Gram-negative bacteria isolated from humans and animals.
    Silva N; Radhouani H; Gonçalves A; Araújo C; Rodrigues J; Igrejas G; Poeta P
    J Antimicrob Chemother; 2010 Apr; 65(4):801-3. PubMed ID: 20110342
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibiotic sensitivity pattern of common community-acquired uropathogens in children in a Saudi tertiary care hospital.
    Al-Saif MA; Al-Abdi SY; Samara JT; Al-Rahman NG; Mousa TA; Alabdulbaqi MA; Yiannakou NG
    Saudi Med J; 2012 May; 33(5):565-7. PubMed ID: 22588821
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparative analysis of the antibiotic sensitivity determination methods of conventionally pathogenic bacteria--agents of human opportunistic infections].
    Kulia AF; Sabo Iu; Koval' HM; Boĭko NV
    Mikrobiol Z; 2011; 73(5):47-53. PubMed ID: 22164699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens.
    Cobo J; Oliva J; Sanz J; Aguado JM; Del Pozo JL; Moreno S
    Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):569-72. PubMed ID: 12938003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.